Details
Regulatory Determination / Use
FDA decided that no action is necessary at this time, based on available information.
Result(s) (1)
PROMPT: Rivaroxaban Surveillance
Related Publication(s) and/or Presentation(s) (1)
Publication: Prospective Surveillance Pilot of Rivaroxaban Safety within the US Food and Drug Administration Sentinel System